The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs. All eventually passed muster.Dr. Marty Makary, the F.D.A. commissioner.
F.D.A. Posts Collection of Letters Outlining Concerns About New Drugs
Scritto il 10/07/2025
da Christina Jewett and Rebecca Robbins